H Schupke

Summary

Affiliation: elbion AG
Country: Germany

Publications

  1. ncbi New metabolic pathways of alpha-lipoic acid
    H Schupke
    Department of Metabolism and Development, elbion AG, Radebeul, Germany
    Drug Metab Dispos 29:855-62. 2001
  2. ncbi Metabolism of retigabine (D-23129), a novel anticonvulsant
    R Hempel
    Corporate Research and Development ASTA Medica Group, Radebeul, Germany
    Drug Metab Dispos 27:613-22. 1999

Collaborators

Detail Information

Publications2

  1. ncbi New metabolic pathways of alpha-lipoic acid
    H Schupke
    Department of Metabolism and Development, elbion AG, Radebeul, Germany
    Drug Metab Dispos 29:855-62. 2001
    ..Furthermore, new data are presented that suggest conjugation with glycine occurred as a separate metabolic pathway in competition with beta-oxidation, predominantly in mice...
  2. ncbi Metabolism of retigabine (D-23129), a novel anticonvulsant
    R Hempel
    Corporate Research and Development ASTA Medica Group, Radebeul, Germany
    Drug Metab Dispos 27:613-22. 1999
    ..We found that in vitro assays with liver slices from rat and humans reveal the major circulating metabolites in vivo...